UDG Healthcare acquires Putnam Associates and Incisive HealthUDG Healthcare has boosted its Ashfield Communications and Advisory business with a brace of deals, acquiring Putnam Associates Share XUDG Healthcare acquires Putnam Associates and Incisive Healthhttps://pharmaphorum.com/news/udg-healthcare-putnam-incisive-health/
Shingles vaccine boosts GSK as generic Advair bitesGSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of Share XShingles vaccine boosts GSK as generic Advair biteshttps://pharmaphorum.com/news/shingles-vaccine-boosts-gsk-as-generic-advair-bites/
FDA approves first medical device ADHD treatmentUS regulators have given the green-light for the first medical device to treat attention deficit hyperactivity disorder (ADHD). Share XFDA approves first medical device ADHD treatmenthttps://pharmaphorum.com/news/fda-approves-neurosigma-adhd/
The Bloc promotes Jennifer Matthews to CEO and presidentNew York-based healthcare creative agency The Bloc has promoted managing partner Jennifer Matthews to CEO and president. It’s Share XThe Bloc promotes Jennifer Matthews to CEO and presidenthttps://pharmaphorum.com/news/the-bloc-promotes-jennifer-matthews-ceo/
Boehringer’s blockbuster Spiriva under pressure, profits downBoehringer Ingelheim has announced an increase in sales for full year 2018, but a slight decline in profits, Share XBoehringer’s blockbuster Spiriva under pressure, profits downhttps://pharmaphorum.com/news/boehringer-ingelheim-2018-sales-profits/
Catalent acquires gene therapy specialist Paragon for $1.2bnDrug delivery technology provider Catalent is to acquire gene therapy company Paragon for $1.2 billion. Paragon specialises in Share XCatalent acquires gene therapy specialist Paragon for $1.2bnhttps://pharmaphorum.com/news/catalent-acquires-gene-therapy-paragon/
Mesoblast poised to file cell therapy for GVHD in USAustralian biotech Mesoblast can go ahead with a US filing for its off-the-shelf stem cell therapy for acute Share XMesoblast poised to file cell therapy for GVHD in UShttps://pharmaphorum.com/news/mesoblast-cell-therapy-gvhd-fda/
Hall & Partners promotes Sue Klinck to global people roleHall & Partners has promoted Sue Klinck to the newly-created role of global head of people and culture. Share XHall & Partners promotes Sue Klinck to global people rolehttps://pharmaphorum.com/news/hall-partners-sue-klinck/
Gillian Wain and Sue Eales join comms agency Makara HealthMakara Health has boosted its team with the appointments of Gillian Wain as account director and Sue Eales Share XGillian Wain and Sue Eales join comms agency Makara Healthhttps://pharmaphorum.com/news/gillian-wain-sue-eales-makara-health/
FCB Health NY makes Kathleen Nanda executive creative directorKathleen Nanda has been promoted to executive creative director of FCB Health New York. She joined the communications Share XFCB Health NY makes Kathleen Nanda executive creative directorhttps://pharmaphorum.com/news/fcb-health-new-york-kathleen-nanda/
Frances O’Connor joins Lucid Group’s Leading Edge companyLucid Group has appointed Frances O’Connor as client partnership director at its strategic health communications and medical education Share XFrances O’Connor joins Lucid Group’s Leading Edge companyhttps://pharmaphorum.com/news/frances-o-connor-lucid-leading-edge/
Alice Choi appointed HCA chairpersonThe Healthcare Communications Association (HCA) has appointed Alice Choi, chief operating officer at McCann Health Medical Communications, as Share XAlice Choi appointed HCA chairpersonhttps://pharmaphorum.com/news/alice-choi-hca-chairperson/
Avenir Global acquires healthcare PR consultancy HanoverPictured above: Hanover’s executive committee and Avenir’s Ralph Sutton. From left, back row – Jonty Summers, Michael Prescott, Share XAvenir Global acquires healthcare PR consultancy Hanoverhttps://pharmaphorum.com/news/avenir-global-acquires-hanover/
Intouch Solutions hires Ann Cave to lead new Boston officeIntouch Solutions has opened an office in Boston, recruiting Ann Cave to its second office on the East Share XIntouch Solutions hires Ann Cave to lead new Boston officehttps://pharmaphorum.com/news/intouch-solutions-ann-cave-boston-office/
McCann Health bolsters leadership team in EuropeMcCann Health has announced three key appointments to its leadership in Europe. Nick Bartlett joins as president of Share XMcCann Health bolsters leadership team in Europehttps://pharmaphorum.com/news/mccann-health-bolsters-leadership-team-europe/
Smith & Nephew buys Osiris in regenerative medicine pushMedical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics Share XSmith & Nephew buys Osiris in regenerative medicine pushhttps://pharmaphorum.com/news/smith-nephew-buys-osiris-regenerative-medicine/
Bedrock appoints Emily Howman to lead scientific services teamBedrock Healthcare Communications has appointed Emily Howman to lead its scientific services team in a move designed to Share XBedrock appoints Emily Howman to lead scientific services teamhttps://pharmaphorum.com/news/bedrock-healthcare-communications-emily-howman/
Alnylam to seek approval for second RNAi drugAlnylam thinks it has strong enough clinical data for its gene-silencing drug for rare disease acute hepatic porphyria Share XAlnylam to seek approval for second RNAi drughttps://pharmaphorum.com/news/alnylam-approval-second-rnai-drug/
